Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

ARCEDI is a biotech company, develops technologies and methods for detecting and diagnosing rare cancer cells, as well as methods that will replace placenta biopsies with blood samples. ARCEDI provide a simpler, safer and accurate non-invasive prenatal diagnostic test to the pregnant women by analyzing the genome of the fetus using circulating fetal cells in maternal blood.

Angioblast Systems, Inc., a biotechnology company, engages in the development and commercialization of therapeutic products for the treatment of cardiovascular diseases. It provides adult stem cells, protein therapeutics, gene silencing, small molecule peptides and antibodies, cytokines and antigen-receptor inhibitors, and DNAzymes, as well as MPC products for heart failure, heart attacks, peripheral artery diseases, and wound ulcers. The company has a strategic alliance with Mesoblast Limited. Angioblast Systems, Inc. was founded in 2001 and is headquartered in New York, New York.

Assistance Publique H��pitaux de Marseille is a private company headquartered in Marseille, France, specializing in general medical and surgical hospitals.

Fresenius Medical Care is a provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 1.89 million individuals worldwide. It has a network of 2,716 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. It offers specialty pharmacy and laboratory services and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Bad Homburg, Frankfurt.

Meridigen Biotech Co. Ltd. is a Taiwanese private company located in Zhubei that provides biotechnology and management consulting services.

Multitude provides software and analytical tools to assist industry and government leaders in turning data from the scattered, emerging web of environmental sensing devices into useful information and plans to support a responsive environment. Its technology integrates data from a variety of different device kinds. The business is committed to making environmental policy and action more equal, transparent, efficient, and cost-effective.

CellSeed Inc. develops regenerative medicine products. It operates through the Cell Sheet Regenerative Medicine and Intelligent Regenerative Medicine Support segments. The Cell Sheet Regenerative Medicine segment provides research, development, marketing, and sale of epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis. The Regenerative Medicine Support segment conducts research and development, manufacturing, and sales of temperature-responsive cell culture equipment. The company was founded by Yukio Hasegawa on May 9, 2001 and is headquartered in Tokyo, Japan.

Medipost Co., Ltd. engages in the development and manufacture of stem cell biotechnology products. It operates through the following business divisions: Cord Blood Bank, Stem Cell Therapy, Health Functional Food, Import and Distribution of Natural Cosmetics and Healthcare Services. The Cord Blood Bank division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapy division manufactures allogeneic stem cell drug products. The Health Functional Food division offers vitamins and nutritional supplements. The Import and Distribution of Natural Cosmetics division is involved in the sales and marketing of natural cosmetics imported by Pevonia Inc. The Healthcare Services division provides healthcare solutions such as bizcare, insu-care, affiliate, telehealth services and medical devices through web, mobile, and call centers. The company was founded by Yoon-Sun Yang and Won-Il Oh on June 26, 2000 and is headquartered in Seongnam, South Korea.

Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway.

MyCartis is a privately held immunodiagnostics company, providing next generation solutions to detect and quantify protein biomarker signatures by providing precise and personalized novel clinical information for the benefit of researchers, clinicians and CRO’s. MyCartis’ Evalution® platform with Dynamic Multi-Analyte Technology (DMAT®) inside, provides a unique multiplex biomarker platform in combination with the required sensitivity and dynamic range for the integrated analysis of protein biomarkers. DMAT® utilizes proprietary disk-shaped micro-particles which carry a unique code and can be functionalized with specific proteins, antibodies, nucleic acids or other molecules. Thanks to th

CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. They develop prognostic tests to identify patients at risk of cardiovascular and disease. The company identified several novel biomarkers predictive for cardiovascular events. It is their goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.

Rebirth Pharmaceutical Technology (Beijing) Co., Ltd., established on 2004-10-09, Business scope includes biotechnology development,Technology Promotion,technology transfer,technical consulting,Technical Services.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Tulane Educational Fund is a private company headquartered in the United States specializing in radio broadcasting stations.

Part of Miltenyi GmbH, Miltenyi Biotec BV & Co. KG is a company headquartered in Bergisch Gladbach, Germany, that manufactures pharmaceutical products.